A00XAlternative Names: A 00X
Latest Information Update: 28 Dec 2016
At a glance
- Originator MeiraGTx
- Class Gene therapies
- Mechanism of Action Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Xerostomia
Most Recent Events
- 12 Dec 2016 Phase-I clinical trials in Xerostomia in USA (PO) (MeiraGTx's website, December 2016)